What is the dosage of Venclexta?

Venclexta is available in 4 dosages, including 10 mg Tab, 100 mg Tab, 50 mg Tab and mixed Pack

What does Venclexta treat?

Venclexta treats Lymphoid Leukemia

What is Venclexta made of?

Venclexta contains venetoclax which is a BCL-2 Inhibitor

How is Venclexta administered?

Venclexta is administered as a Oral Pill or Pack

What is Venclexta mechanism of action?

Venclexta mechanism of action is P-Glycoprotein Inhibitors

Dosage & Administration Biomarker testing Drug label Prior authorization Pharmacy Financial assistance

Patient education People also ask

Venclexta

(venetoclax)

venetoclax 10 MG Oral Tablet [Venclexta]venetoclax 100 MG Oral Tablet [Venclexta]

View 1 more

NO BLACK BOX WARNING

Dosage & administration

* See Full Prescribing Information for recommended VENCLEXTA dosages.

* Take VENCLEXTA tablets orally once daily with a meal and water. Do not chew, crush, or break tablets.

* Provide prophylaxis for tumor lysis syndrome.

biomarker testing

Venclexta clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Venclexta prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Venclexta prior authorization resources

OTHERComplete Letter of Medical Necessity

OTHERCoverage Authorization Appeals

Learn More

Benefits investigation

PDFVenclexta Prescriber Service Form

PDFVenclexta Patient Consent Form

PDFVenclexta Patient Consent Form - Spanish

Learn More

pharmacy

Venclexta preferred pharmacy

OTHERPharmacy List

financial assistance

Venclexta financial assistance options

Co-pay savings program

commercial only

PDFVenclexta Prescriber Service Form

PDFVenclexta Patient Consent Form

PDFVenclexta Patient Consent Form - Spanish

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

PDFVenclexta Prescriber Service Form

OTHERVenclexta Sure Start Program (Bridge Program)

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

PDFVenclexta Prescriber Service Form

PDFVenclexta Patient Consent Form

PDFVenclexta Patient Consent Form - Spanish

PDFGenentech Patient Foundation Application Form (1/2)

PDFGenentech Patient Foundation Application Form (2/2) - Patient Consent Form

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.